Monashee Investment Management LLC
Follow13F filer, CIK 1627608, Boston, MA
Monashee Investment Management LLC reported $33,404,308 across 16 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-06. Its ten largest share positions make up 88.42% of the portfolio.
Accepted , ingested 13F-HR 0001172661-26-004876
- Period
- 2026-09-30
- Reported value
- $33.4M
- Holdings
- 16
- Top 10 weight
- 88.42%
- New
- 13
- Sold out
- 20
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AXON ENTERPRISE INCnew | +5,000,000 | $4.94M |
| IMMXnew | +450,000 | $4.68M |
| SYYnew | +55,000 | $4.29M |
| NWCLnew | +400,000 | $3.14M |
| ENBnew | +50,000 | $2.32M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| GOOGMexited | -100,000 | -$5.09M |
| GOOGNexited | -100,000 | -$5.03M |
| DLRexited | -25,000 | -$4.49M |
| SYREexited | -50,000 | -$4.44M |
| TNGXexited | -100,000 | -$3.13M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001172661-26-004876, largest first. % of portfolio is the value over $33,404,308, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| AXON ENTERPRISE INCAXON ENTERPRISE INC | 5,000,000 | $4.94M | 14.8% | new | |||
| IMMXIMMIX BIOPHARMA INC | 450,000 | $4.68M | 14.02% | new | Timeline | ||
| SYYSYSCO CORP | 55,000 | $4.29M | 12.84% | new | Timeline | ||
| NWCLNEWCLEO PLC | 400,000 | $3.14M | 9.4% | new | Timeline | ||
| ADTADT INC DEL | 500,000 | $3.04M | 9.1% | -100,000 | Timeline | ||
| SLDBSOLID BIOSCIENCES INC | 410,000 | $2.96M | 8.87% | -90,000 | Timeline | ||
| ENBENBRIDGE INC | 50,000 | $2.32M | 6.96% | new | Timeline | ||
| VIKING THERAPEUTICS INCVIKING THERAPEUTICS INC | 1,500,000 | $1.54M | 4.6% | new | |||
| BLSMBLOSSOMHILL THERAPEUTICS INC | 80,000 | $1.49M | 4.46% | new | Timeline | ||
| ETRAELECTRA THERAPEUTICS INC | 100,000 | $1.12M | 3.37% | new | Timeline | ||
| YARWYARROW BIOSCIENCE INC | 40,000 | $901K | 2.7% | new | Timeline | ||
| IMAIMAGENEBIO INC | 177,094 | $811K | 2.43% | -15,250 | Timeline | ||
| AVAHAVEANNA HEALTHCARE HLDGS INC | 50,000 | $620K | 1.86% | new | Timeline | ||
| PYXSPYXIS ONCOLOGY INC | 229,310 | $534K | 1.6% | new | Timeline | ||
| OIGORION180 INS GROUP INC | 55,000 | $530K | 1.59% | new | Timeline | ||
| HGTYHAGERTY INC | 35,000 | $471K | 1.41% | new | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| GOOGMALPHABET INC | 100,000 | $5.09M | shares |
| GOOGNALPHABET INC | 100,000 | $5.03M | shares |
| DLRDIGITAL RLTY TR INC | 25,000 | $4.49M | shares |
| SYRESPYRE THERAPEUTICS INC | 50,000 | $4.44M | shares |
| TNGXTANGO THERAPEUTICS INC | 100,000 | $3.13M | shares |
| CELCUITY INCCELCUITY INC | 2,500,000 | $2.84M | principal |
| SMCIPSUPER MICRO COMPUTER INC | 50,000 | $2.6M | shares |
| LEGNLEGEND BIOTECH CORP | 85,385 | $2.47M | shares |
| GOOGLALPHABET INC | 6,000 | $2.14M | shares |
| GOOGALPHABET INC | 6,000 | $2.12M | shares |
| QUREUNIQURE NV | 45,000 | $2.07M | shares |
| INIOINNIO NV | 47,650 | $1.88M | shares |
| AKRACADIA RLTY TR | 85,385 | $1.79M | shares |
| PTRNPATTERN GROUP INC | 64,039 | $1.61M | shares |
| PURECYCLE TECHNOLOGIES INCPURECYCLE TECHNOLOGIES INC | 1,500,000 | $1.53M | principal |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS | 75,000 | $1.46M | shares |
| WHKWHITEHAWK MINERALS CORP | 51,232 | $1.43M | shares |
| TSHATAYSHA GENE THERAPIES INC | 200,000 | $1.36M | shares |
| NUVATION BIO INCNUVATION BIO INC | 1,000,000 | $1.06M | principal |
| KARDKARDIGAN INC | 42,693 | $1.02M | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-26-004876 | base | 2026-11-06 |